These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38296728)

  • 1. Retraction notice to "miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer" [Biomed. Pharmacother. 95 (2017) 1718-1724].
    Lin Y; Cheng K; Wang T; Xie Q; Chen M; Chen Q; Wen Q
    Biomed Pharmacother; 2024 Feb; 171():116187. PubMed ID: 38296728
    [No Abstract]   [Full Text] [Related]  

  • 2. Retraction notice to "Alkannin inhibits proliferation, migration and invasion of hepatocellular carcinoma cells via regulation of miR-92a" [Biomed. Pharmacother. 114 (2019) 108782].
    Sun B; Zhang J; Liu M; Guan L
    Biomed Pharmacother; 2022 Feb; 146():112626. PubMed ID: 35031232
    [No Abstract]   [Full Text] [Related]  

  • 3. Retraction notice to "Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a" [Biomed. Pharmacother. 112 (2019) 108592].
    Xu F; Li Q; Wang Z; Cao X
    Biomed Pharmacother; 2022 Apr; 148():112781. PubMed ID: 35272893
    [No Abstract]   [Full Text] [Related]  

  • 4. Retraction notice to "Icariin inhibits cell proliferation, migration and invasion by down-regulation of microRNA-625-3p in thyroid cancer cells" [Biomed. Pharmacother. 109 (2019) 2456-2463].
    Fang L; Xu W; Kong D
    Biomed Pharmacother; 2022 Jun; 150():112851. PubMed ID: 35341632
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "Neferine inhibits proliferation, migration and invasion of U251 glioma cells by down-regulation of miR-10b" [Biomed. Pharmacother. 109 (2019) 1032-1040].
    Liang HX; Sun LB; Liu NJ
    Biomed Pharmacother; 2021 Dec; 144():112388. PubMed ID: 34772580
    [No Abstract]   [Full Text] [Related]  

  • 6. miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer.
    Lin Y; Cheng K; Wang T; Xie Q; Chen M; Chen Q; Wen Q
    Biomed Pharmacother; 2017 Nov; 95():1718-1724. PubMed ID: 28962076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retraction notice to "miR-367 regulation of DOC-2/DAB2 interactive protein promotes proliferation, migration and invasion of osteosarcoma cells" [Biomed. Pharmacother. 95 (2017) 120-128].
    Cai W; Jiang H; Yu Y; Xu Y; Zuo W; Wang S; Su Z
    Biomed Pharmacother; 2023 Apr; 160():114282. PubMed ID: 36725469
    [No Abstract]   [Full Text] [Related]  

  • 8. Retraction notice to "Ailanthone exerts anticancer effect by up-regulating miR-148a expression in MDA-MB-231 breast cancer cells and inhibiting proliferation, migration and invasion" [Biomed. Pharmacother. 109 (2019) 1062-1069].
    Gao W; Ge S; Sun J
    Biomed Pharmacother; 2022 Jun; 150():112854. PubMed ID: 35341636
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraction notice to "miR-217 represses TGF-β1-induced airway smooth muscle cell proliferation and migration through targeting ZEB1 " [Biomed. Pharmacother. 108 (2018) 27-35].
    Gao Y; Wang B; Luo H; Zhang Q; Xu M
    Biomed Pharmacother; 2023 Sep; 165():114805. PubMed ID: 37183050
    [No Abstract]   [Full Text] [Related]  

  • 10. Retraction notice to "lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer" [Biomed. Pharmacother. 114 (2019) 108814].
    Jiang F; Qi W; Wang Y; Wang W; Fan L
    Biomed Pharmacother; 2022 Jan; 145():112511. PubMed ID: 34895810
    [No Abstract]   [Full Text] [Related]  

  • 11. Retraction notice to "MiR-539 inhibits human colorectal cancer progression by targeting RUNX2″ [Biomed. Pharmacother. 95 (2017) 1314-1320].
    Wen D; Li S; Jiang W; Zhu J; Liu J; Zhao S
    Biomed Pharmacother; 2023 Nov; 167():115375. PubMed ID: 37802728
    [No Abstract]   [Full Text] [Related]  

  • 12. Retraction notice to "LncRNA DICER1-AS1 promotes the proliferation, invasion and autophagy of osteosarcoma cells via miR-30b/ATG5" [Biomed. Pharmacother., 104 (2018) 110-118].
    Gu Z; Hou Z; Zheng L; Wang X; Wu L; Zhang C
    Biomed Pharmacother; 2024 Mar; 172():116198. PubMed ID: 38296734
    [No Abstract]   [Full Text] [Related]  

  • 13. Retraction notice to "Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma" [Biomed. Pharmacother. 109 (2019) 798-805].
    Qi D; Wang M; Yu F
    Biomed Pharmacother; 2022 Jun; 150():112855. PubMed ID: 35341635
    [No Abstract]   [Full Text] [Related]  

  • 14. Retraction notice to "Long noncoding RNA HOXD-AS1 promotes non-small cell lung cancer migration and invasion through regulating miR-133b/MMP9 axis" [Biomed. Pharmacother. 106 (2018) 156-162].
    Xia H; Jing H; Li Y; Lv X
    Biomed Pharmacother; 2023 Dec; 169():115376. PubMed ID: 38016887
    [No Abstract]   [Full Text] [Related]  

  • 15. Retraction notice to "MicroRNA-361-5p inhibits papillary thyroid carcinoma progression by targeting ROCK1" [Biomed. Pharmacother. 102 (2018) 988-995].
    Li R; Dong B; Wang Z; Jiang T; Chen G
    Biomed Pharmacother; 2023 Aug; 164():114723. PubMed ID: 37088668
    [No Abstract]   [Full Text] [Related]  

  • 16. Retraction notice to "Baicalein inhibits proliferation and migration of bladder cancer cell line T24 by down-regulation of microRNA-106" [Biomed. Pharmacother. 107 (2018) 1583-1590].
    Jiang L; Song H; Guo H; Wang C; Lu Z
    Biomed Pharmacother; 2020 Oct; 130():110634. PubMed ID: 32843236
    [No Abstract]   [Full Text] [Related]  

  • 17. MicroRNA-338-3p inhibits thyroid cancer progression through targeting AKT3.
    Sui GQ; Fei D; Guo F; Zhen X; Luo Q; Yin S; Wang H
    Am J Cancer Res; 2017; 7(5):1177-1187. PubMed ID: 28560065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retraction notice to "miR-149 regulates the proliferation and apoptosis of cervical canc er cells by targeting GIT1" [Biomed. Pharmacother. 105 (2018) 1106-1116].
    Qian B; Zhao L; Wang X; Xu J; Teng F; Gao L; Shen R
    Biomed Pharmacother; 2020 May; 125():109971. PubMed ID: 32070646
    [No Abstract]   [Full Text] [Related]  

  • 19. Retraction notice to "LINC01116 targets miR-520a-3p and affects IL6R to promote the proliferation and migration of osteosarcoma cells through the Jak-stat signaling pathway" [Biomed. Pharmacother. 107 (2018) 270-282].
    Zhang B; Yu L; Han N; Hu Z; Wang S; Ding L; Jiang J
    Biomed Pharmacother; 2024 Apr; 173():116325. PubMed ID: 38443290
    [No Abstract]   [Full Text] [Related]  

  • 20. Retraction notice to: "LncRNA DANCR silence inhibits SOX5-medicated progression and autophagy in osteosarcoma via regulating miR-216a-5p" [Biomed. Pharmacother. 122 (2019) 109707].
    Pan Z; Wu C; Li Y; Li H; An Y; Wang G; Dai J; Wang Q
    Biomed Pharmacother; 2023 Oct; 166():114876. PubMed ID: 37353384
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.